Activated Clotting Times in the Setting of Eptifibatide Use During Percutaneous Coronary Intervention Harold L. DauermanSteven A. BallMark I. Furman OriginalPaper Pages: 127 - 132
The Smoker's Paradox: Insights from the Angiographic Substudies of the TIMI Trials Brad G. AngejaSarah KermgardC. Michael Gibson OriginalPaper Pages: 133 - 139
Abciximab is Rapidly Effective in Preventing and Arresting Established Platelet Aggregation Miles C. DalbySimon J. DavidsonSimon W. Davies OriginalPaper Pages: 141 - 145
Feasibility and Timing of Prehospital Administration of Reteplase in Patients with Acute Myocardial Infarction Donald G. RosenbergEsther LevinMary Gunn OriginalPaper Pages: 147 - 153
Anticoagulant Therapy with a Selective Thrombin Inhibitor for Acute Cerebral Infarction: Usefulness of Coagulation Markers for Evaluation of Efficacy Takao UrabeRyota TanakaYoshikuni Mizuno OriginalPaper Pages: 155 - 160
Decreased Platelet Reactivity in Blood Anticoagulated with Bivalirudin or Enoxaparin Compared with Unfractionated Heparin: Implications for Coronary Intervention Atul AggarwalBurton E. SobelDavid J. Schneider OriginalPaper Pages: 161 - 165
A Reconstituted In Vitro Clot Model for Evaluating Laser Thrombolysis Abram D. JanisLisa A. BuckleyKenton Gregory OriginalPaper Pages: 167 - 175
Antiplatelet Therapies in Combination for the Treatment of Patients with Stable and Unstable Coronary Artery Disease Ronnier J. AvilesDeepak L. Bhatt OriginalPaper Pages: 177 - 182
Outpatient Management of Venous Thromboembolic Disease with Subcutaneous Lepirudin: A Case Report Susan M. BegelmanSteven R. Deitcher ReviewPaper Pages: 183 - 185
The Association of Mondor's Disease with Protein S Deficiency: Case Report and Review of Literature José Maria Pereira de GodoyMoacir Fernandes GodoyDomingo Marcolino Braile ReviewPaper Pages: 187 - 189
Benefits of Late Reperfusion in the Treatment of Acute Myocardial Infarction Kinji Ishikawa ReviewPaper Pages: 191 - 200
